WeightWatchers Completes $1.15B Debt Cut, Appoints CMO, Launches Menopause Program

WeightWatchers (WW International Inc.) has successfully completed a strategic financial reorganization, eliminating $1.15 billion in debt and emerging from bankruptcy to relist on Nasdaq. With strengthened financial flexibility, the company is accelerating its transformation by innovating its digital and member experiences and expanding its telehealth business. Key leadership appointments include Dr. Kim Boyd as Chief Medical Officer, who will lead clinical strategy and integrate emerging science such as GLP-1 weight-loss drugs with lifestyle programs, and Uta Knablein as Chief Product Officer to drive product innovation. WeightWatchers is launching a new comprehensive program targeted at women experiencing perimenopause, menopause, and postmenopause, combining nutritional, behavioral strategies, specialized clinical care, coaching, and community support. The company aims to address broader healthcare gaps by integrating medical science and community support to improve weight management outcomes. These initiatives, alongside the addition of industry experts to the board, underscore WeightWatchers' commitment to evolving its offerings in the rapidly changing weight management landscape.